• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • The current status of heart failure diagnostic biomarkers

    Thumbnail
    View/Open
    Punyadeera521841-Accepted.pdf (618.9Kb)
    File version
    Accepted Manuscript (AM)
    Author(s)
    Zhang, Xi
    Schulz, Benjamin L
    Punyadeera, Chamindie
    Griffith University Author(s)
    Punyadeera, Chamindie
    Year published
    2016
    Metadata
    Show full item record
    Abstract
    Heart failure (HF) affects approximately 23 million individuals worldwide and this number is increasing, due to an aging and growing population. Early detection of HF is crucial in the management of this debilitating disease. Current diagnostic methods for HF rely heavily on clinical imaging techniques and blood analysis, which makes them less than ideal for population-based screening purposes. Studies focusing on developing novel biomarkers for HF have utilized various techniques and biological fluids, including urine and saliva. Promising results from these studies imply that these body fluids can be used in evaluating the ...
    View more >
    Heart failure (HF) affects approximately 23 million individuals worldwide and this number is increasing, due to an aging and growing population. Early detection of HF is crucial in the management of this debilitating disease. Current diagnostic methods for HF rely heavily on clinical imaging techniques and blood analysis, which makes them less than ideal for population-based screening purposes. Studies focusing on developing novel biomarkers for HF have utilized various techniques and biological fluids, including urine and saliva. Promising results from these studies imply that these body fluids can be used in evaluating the clinical manifestation of HF and will one day be integrated into a clinical workflow and facilitate HF management.
    View less >
    Journal Title
    Expert Review of Molecular Diagnostics
    Volume
    16
    Issue
    4
    DOI
    https://doi.org/10.1586/14737159.2016.1144474
    Copyright Statement
    This is an Author's Accepted Manuscript of an article published in the Expert Review of Molecular Diagnostics, 16 (4), pp. 487-500, 17 Feb 2016, copyright Informa UK Limited, trading as Taylor & Francis Group, available online at: https://doi.org/10.1586/14737159.2016.1144474
    Subject
    Clinical sciences
    Cardiology (incl. cardiovascular diseases)
    Science & Technology
    Life Sciences & Biomedicine
    Pathology
    Biomarker
    Diagnostic
    Publication URI
    http://hdl.handle.net/10072/412139
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander